Global market for antifungal drugs & technologies worth $11.8 billion by 2014

The global human antifungal therapeutics market was worth around $10.2 billion in 2008 and it decreased in 2009 to be around $9.9 billion. However, the market is anticipated to reach $11.8 billion in 2014 at a 5 year CAGR of 3.8%.

Learn about the major markets for antifungal applications in human healthcare, with an extensive review of therapies in human development phases I-III...

Use this report to:

• Receive in-depth analysis of the current human antifungal market and explore the direction the market is going, with a strong emphasis on early research due to the critical need for new and more effective medicines
• Understand the human applications both marketed and in the development of antifungal technology; extensive analysis of each market segment, current market status, and forecasts for growth over the next 5 years
• See 5-year financial and sales projections and trends from 2009 through 2014; based on other factors such as FDA restrictions, government legislation, fungal resistance, and changes in the consumerism as a greater demand for OTC medications and/or natural and alternative remedies has arose
• Determine the current status of the global human antifungal market and assess its growth potential over the 5 year period from 2009 through 2014.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.